Neurontin (Gabapentin)

Gabapentin, the active ingredient in Neurontin, is a GABA analog anticonvulsant presented as an oral formulation for oral use. It is prescribed for the management of partial seizures and various neuropathic pain conditions, including post‑herpetic neuralgia, diabetic peripheral neuropathy, and restless‑legs syndrome, in adult patients.

GNH USA supplies Neurontin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across markets. Our distribution network adheres to stringent quality standards and facilitates reliable access to essential medicines.

Neurontin (gabapentin) acts on neuronal calcium channels to treat several seizure‑related and neuropathic pain disorders. - Partial seizures: reduces seizure frequency in adults with focal epilepsy. - Post‑herpetic neuralgia: alleviates chronic pain following shingles infection. - Diabetic peripheral neuropathic pain: diminishes burning and tingling sensations in diabetic patients. - Restless‑legs syndrome: lessens uncomfortable leg sensations and urges to move, improving sleep quality.

Common Side Effects: - Dizziness: sensation of light‑headedness or unsteadiness. - Somnolence: increased sleepiness or fatigue. - Peripheral edema: swelling of the lower extremities. - Weight gain: gradual increase in body weight. - Ataxia: loss of coordination and balance. - Fatigue: general feeling of tiredness.

Serious or Rare Side Effects: - Suicidal thoughts or behavior: mood changes requiring immediate medical attention. - Severe allergic reactions: including Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Respiratory depression: especially when combined with other CNS depressants. - Angioedema: rapid swelling of face, lips, or throat. - Blood dyscrasias: such as agranulocytosis or thrombocytopenia. - Hepatic failure: signs of liver dysfunction requiring urgent care.

Neurontin should be used with careful clinical assessment and monitoring. - Renal function: dose adjustment may be required in patients with impaired renal clearance. - Pregnancy: safety not established; prescribe only if potential benefit outweighs risk. - Suicidality: monitor for mood changes and suicidal ideation throughout therapy. - Driving: caution advised due to possible dizziness or somnolence. - Drug interactions: review concomitant medications for CNS depressants. - Store at ambient temperature: keep in the original container, protect from moisture and heat.

Gabapentin may interact with several medications, requiring vigilance. Major Interactions (Avoid): - Antacids containing aluminum or magnesium: may reduce gabapentin absorption. - Opioids: increased risk of respiratory depression and sedation. - CNS depressants (benzodiazepines, barbiturates): additive central nervous system depression. Moderate Interactions (Monitor Closely): - ACE inhibitors: may increase gabapentin plasma levels. - Diuretics: may affect renal clearance of gabapentin. - Carbamazepine: may reduce gabapentin efficacy.